Heartland Advisors Inc. maintained its position in shares of Safeguard Scientifics Inc. (NYSE:SFE) during the third quarter, Holdings Channel reports. The firm owned 400,000 shares of the company’s stock at the end of the third quarter. Heartland Advisors Inc.’s holdings in Safeguard Scientifics were worth $5,184,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. JPMorgan Chase & Co. boosted its position in shares of Safeguard Scientifics by 13.0% in the first quarter. JPMorgan Chase & Co. now owns 86,888 shares of the company’s stock worth $1,151,000 after buying an additional 10,000 shares during the last quarter. Foundry Partners LLC boosted its position in shares of Safeguard Scientifics by 0.3% in the second quarter. Foundry Partners LLC now owns 166,794 shares of the company’s stock worth $2,083,000 after buying an additional 475 shares during the last quarter. First Manhattan Co. boosted its position in shares of Safeguard Scientifics by 0.5% in the second quarter. First Manhattan Co. now owns 1,693,363 shares of the company’s stock worth $21,150,000 after buying an additional 8,605 shares during the last quarter. LaSalle Street Capital Management LLC boosted its position in shares of Safeguard Scientifics by 2.5% in the second quarter. LaSalle Street Capital Management LLC now owns 11,714 shares of the company’s stock worth $146,000 after buying an additional 287 shares during the last quarter. Finally, Bank of Montreal Can acquired a new position in shares of Safeguard Scientifics during the second quarter worth approximately $5,664,000. Institutional investors and hedge funds own 79.56% of the company’s stock.
Shares of Safeguard Scientifics Inc. (NYSE:SFE) traded down 0.183% on Monday, reaching $12.028. 14,247 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $12.29 and a 200 day moving average price of $12.95. Safeguard Scientifics Inc. has a one year low of $10.60 and a one year high of $16.48. The firm’s market cap is $243.42 million.
Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings data on Thursday, October 27th. The company reported ($1.18) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.74) by $0.44. During the same quarter in the previous year, the firm earned ($0.56) earnings per share. Analysts expect that Safeguard Scientifics Inc. will post ($0.34) EPS for the current fiscal year.
Separately, Zacks Investment Research upgraded shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $15.00 price target on the stock in a research report on Wednesday, October 12th.
In related news, CEO Stephen T. Zarrilli acquired 3,900 shares of the stock in a transaction dated Wednesday, September 14th. The shares were purchased at an average cost of $12.75 per share, with a total value of $49,725.00. Following the transaction, the chief executive officer now directly owns 103,606 shares in the company, valued at $1,320,976.50. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 2.67% of the company’s stock.
About Safeguard Scientifics
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).